Trending - Altmetric
- Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityLast mentioned on Thu May 20 2021
- Intracellular Factor H drives tumor progression independently of the complement cascadeLast mentioned on Thu Jun 03 2021
- A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma PatientsLast mentioned on Fri May 21 2021
- Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy EfficacyLast mentioned on Wed May 26 2021
- Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of non-canonical functions of C1sLast mentioned on Sat May 29 2021
- Tumor cells hijack macrophage-produced complement C1q to promote tumor growthLast mentioned on Fri May 21 2021
- Neoepitopes of Cancers: Looking Back, Looking AheadLast mentioned on Tue May 18 2021
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human PrimatesLast mentioned on Mon May 31 2021
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T CellsLast mentioned on Mon May 24 2021
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in HumansLast mentioned on Mon May 31 2021
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsLast mentioned on Mon May 24 2021
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune RegulationLast mentioned on Mon May 31 2021
- VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer ImmunotherapyLast mentioned on Mon May 24 2021
- Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical EffectLast mentioned on Thu May 27 2021
- Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8+ T CellsLast mentioned on Tue Jun 01 2021
- Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor ImmunityLast mentioned on Tue Jun 08 2021
- Repertoire Remodeling through CD4+ T-cell DepletionLast mentioned on Thu Jun 03 2021
Pages